Financing - January 31, 2020
Follicum receives Vinnova grant
Follicum’s grant application to Vinnova to study binding of FOL peptides to receptors on pancreatic cells has been approved. Follicum is the coordinator of the project, which also includes Lund University and SARomics Biostructures. Parts of the project involve advanced analysis work to be performed at the new MAX IV synchrotron facility in Lund. Aims […]
Financing - August 3, 2017
Bonesupport project receives Vinnova grant
Swedish BONESUPPORT has announced that one of the components of its pipeline projects focused on developing a new CERAMENT product capable of enhancing bone growth has been awarded SEK 8 million in external funding from Sweden’s innovation agency Vinnova. The project titled Developing Functionalized Biomaterials with Bone Active Molecules as Novel Strategies/Tools for Secondary Prevention and […]
Collaboration - June 26, 2017
Three new R&D centres receives 100 MSEK
The Swedish Research Council and Vinnova will distribute over 100 million SEK during the coming years to the development of three new centres, with the aim to create strong research and development environments within biopharmaceuticals. This drive is part of an eight year long research program for biologics (320 million SEK) and it is part of the […]
Uncategorized - December 1, 2014
Monocl Receives Vinnova Grant
Monocl Software, a Life Science Intelligence company, has been awarded 2.7 MSEK through VINNOVA’s ‘Forska&Väx’ program. The funding will be used to enable a successful launch of MONOCL EGO in 2015. MONOCL EGO is a groundbreaking expert analytics tool designed to help professional users to find, assess and engage with relevant Life Science experts and […]
Funding - November 25, 2014
Beactica Receives Grant
Beactica, the Swedish fragment-based drug discovery company, announced that it has been awarded a SEK 3.0 million grant from the Swedish Governmental Agency for Innovation Systems (VINNOVA). The grant will be used to support the development of a new epigenetic drug for treatment of cancer. The goal of Beactica’s project is to develop novel compounds for […]
Clinical Trials - July 2, 2014
Karo Bio granted more Vinnova funding for cancer studies
Karo Bio has been granted another SEK 3.8 million from the Swedish innovation agency Vinnova for the preclinical development of an ERbeta agonist for the treatment of different forms of cancer. The financing is granted through the Forska & Väx program and will be paid out in stages during 2014 and early 2015, to finance studies within […]
